Healthpeak Properties, Inc. DOC
20.62 USD +0.36 (+1.78%)
At closeNov 9, 2026, 4:44 PM EST
20.62 0.00 0.00%
After hours · Nov 9, 4:44 PM ET
20.38 Day range 20.81
15.70 52-week range 22.95
- YTD
- +28.23%
- 1 year
- +15.71%
News
benzinga.com Evercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23 Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:DOC) with a In-Line and raises the price target from $22 to $23.
defenseworld.net American Healthcare REIT (NYSE:AHR) versus Healthpeak Properties (NYSE:DOC) Head to Head Comparison Healthpeak Properties (NYSE: DOC - Get Free Report) and American Healthcare REIT (NYSE: AHR - Get Free Report) are both large-cap real estate companies, but which is the better investment? We will…
defenseworld.net AIA Group Ltd Purchases 109,929 Shares of Healthpeak Properties, Inc. $DOC AIA Group Ltd bought a new stake in shares of Healthpeak Properties, Inc. (NYSE: DOC) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange…
benzinga.com Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21 Cantor Fitzgerald analyst Richard Anderson maintains Healthpeak Properties (NYSE:DOC) with a Neutral and lowers the price target from $23 to $21.
fool.com Healthpeak: 3 Key Takeaways for Long-Term Investors Lab buildings bought near existing campuses are targeted to climb from 41% occupancy toward a 9% to 10% stabilized yield, a plan that hinges on local scale.
marketbeat.com What Healthpeak Properties (DOC) Said on Its Q3 Earnings Call Healthpeak Properties NYSE: DOC raised its full-year earnings outlook for the third time in 2026 after reporting what President and Chief Executive Officer Scott Brinker described as a strong…
zacks.com Healthpeak's Q3 FFOA Beat Estimates on Leasing, Senior Housing Growth DOC's Q3 2026 FFOA and revenues beat estimates, driven by solid outpatient leasing and senior housing growth, prompting an upgraded full-year FFOA outlook.
seekingalpha.com Healthpeak Properties, Inc. (DOC) Q3 2026 Earnings Call Transcript Healthpeak Properties, Inc. ( DOC ) Q3 2026 Earnings Call November 3, 2026 10:00 AM EST Company Participants Andrew Johns - Senior Vice President of Investor Relations Scott Brinker - President, CEO…
benzinga.com Healthpeak Properties Q3 2026 Earnings Call Transcript Healthpeak Properties (NYSE:DOC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
zacks.com Healthpeak (DOC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Although the revenue and EPS for Healthpeak (DOC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
zacks.com Healthpeak (DOC) Q3 FFO and Revenues Surpass Estimates Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to FFO of $0.46 per share a year ago.
benzinga.com Healthpeak Properties Raises FY2026 FFO Guidance from $1.73-$1.77 to $1.76-$1.78 vs $1.76 Est Healthpeak Properties (NYSE:DOC) raises FY2026 FFO guidance from $1.73-$1.77 to $1.76-$1.78 vs $1.76 analyst estimate..
benzinga.com Healthpeak Properties Q3 Adj. FFO $0.44 Beats $0.43 Estimate, Sales $820.892M Beat $736.787M Estimate Healthpeak Properties (NYSE:DOC) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.43 by 2.33 percent. This is a 4.35 percent decrease over earnings of…
businesswire.com Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results…
benzinga.com Apple, Palantir On Deck Monday As AI Demand, iPhone Growth Face Test Apple headlines Monday’s reports, with investors looking for continued iPhone momentum and evidence that its artificial-intelligence push can support the company’s next leg of growth. Marriott…
benzinga.com Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19 Wells Fargo analyst James Feldman maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and lowers the price target from $22 to $19.
benzinga.com Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21 Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and lowers the price target from $24 to $21.- benzinga.com Evercore ISI Group Maintains In-Line on Healthpeak Properties, Lowers Price Target to $22 Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:DOC) with a In-Line and lowers the price target from $23 to $22.
benzinga.com Jefferies Assumes Healthpeak Properties at Hold, Lowers Price Target of $21 Jefferies analyst Joe Dickstein assumes Healthpeak Properties (NYSE:DOC) with a Hold rating and lowers Price Target of $21.- benzinga.com Barclays Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $24 Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $23 to $24.
benzinga.com Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.- benzinga.com Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24 Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
- benzinga.com Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22 Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.
- benzinga.com RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24 RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
- benzinga.com Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Raises Price Target to $23 Cantor Fitzgerald analyst Richard Anderson maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $23.
- benzinga.com Healthpeak Properties Q2 FFO $0.46 Beats $0.44 Estimate, Sales $771.579M Beat $719.583M Estimate Healthpeak Properties (NYSE:DOC) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.44 by 4.55 percent. This is unchanged from the same period last year.…
- benzinga.com Healthpeak Properties Raises FY2026 FFO Guidance from $1.71-$1.75 to $1.73-$1.77 vs $1.74 Est Healthpeak Properties (NYSE:DOC) raises FY2026 FFO guidance from $1.71-$1.75 to $1.73-$1.77 vs $1.74 analyst estimate..
- benzinga.com Healthpeak Properties And Brookfield Asset Management Form $2.1B Long-Term Strategic Capital JV Involving Portfolio Of Outpatient Medical Buildings Across US Healthpeak Properties, Inc. (NYSE:DOC) ("Healthpeak") and Brookfield Asset Management (NYSE:BAM, TSX:BAM) ("Brookfield"), today announced the formation of a long-term strategic capital partnership
- benzinga.com Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $22 Wells Fargo analyst John Kilichowski maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $20 to $22.
- benzinga.com Barclays Initiates Coverage On Healthpeak Properties with Equal-Weight Rating, Announces Price Target of $23 Barclays analyst Richard Hightower initiates coverage on Healthpeak Properties (NYSE:DOC) with a Equal-Weight rating and announces Price Target of $23.
- benzinga.com Mizuho Maintains Outperform on Healthpeak Properties, Raises Price Target to $24 Mizuho analyst Vikram Malhotra maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
- benzinga.com JP Morgan Maintains Neutral on Healthpeak Properties, Raises Price Target to $21 JP Morgan analyst Michael Mueller maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $18 to $21.
- benzinga.com BMO Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24 BMO Capital analyst Juan Sanabria maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $20 to $24.
- benzinga.com Morgan Stanley Downgrades Healthpeak Properties to Equal-Weight, Raises Price Target to $22 Morgan Stanley analyst Richard Hill downgrades Healthpeak Properties (NYSE:DOC) from Overweight to Equal-Weight and raises the price target from $20 to $22.
- benzinga.com Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $20 Wells Fargo analyst John Kilichowski maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $18 to $20.
benzinga.com Scotiabank Maintains Sector Perform on Healthpeak Properties, Raises Price Target to $21 Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties (NYSE:DOC) with a Sector Perform and raises the price target from $19 to $21.- benzinga.com Morgan Stanley Maintains Overweight on Healthpeak Properties, Raises Price Target to $20 Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:DOC) with a Overweight and raises the price target from $18 to $20.
benzinga.com RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $21 RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $20 to $21.- benzinga.com Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $21 Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $19 to $21.
- benzinga.com Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $20 Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $17.5 to $20.
benzinga.com Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised guidance. Other gaining stocks include EVC, BLMN, MNKD, FLEX, HUT, AVTX, COMP, VCYT, and SSRM.
benzinga.com Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks With Over 7% Dividend Yields High-dividend stocks are popular in uncertain markets. Benzinga has analyst ratings for many stocks, including accurate ones for high-yield real estate stocks.- benzinga.com Healthpeak Properties Raises FY2026 FFO Guidance from $1.70-$1.74 to $1.71-$1.75 vs $1.75 Est 2026 GUIDANCEWe are updating the following guidance ranges for full year 2026:Diluted earnings per common share from $0.34 – $0.38 to $0.46 – $0.50Diluted Nareit FFO per share from $1.70 – $1.74 to…
- benzinga.com Healthpeak Properties Q1 FFO $0.45 Beats $0.43 Estimate, Sales $752.952M Beat $694.560M Estimate Healthpeak Properties (NYSE:DOC) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.43 by 4.65 percent. This is a 2.17 percent decrease over earnings of…
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com Morgan Stanley Maintains Overweight on Healthpeak Properties, Lowers Price Target to $18 Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:DOC) with a Overweight and lowers the price target from $21 to $18.- benzinga.com UBS Initiates Coverage On Healthpeak Properties with Neutral Rating, Announces Price Target of $17 UBS initiates coverage on Healthpeak Properties (NYSE:DOC) with a Neutral rating and announces Price Target of $17.
benzinga.com Healthpeak Has A BBB+ Rating And 28% Dividend Buffer — But Earnings Base Has Changed - benzinga.com Baird Maintains Outperform on Healthpeak Properties, Lowers Price Target to $19 Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and lowers the price target from $20 to $19.
- benzinga.com Citigroup Maintains Neutral on Healthpeak Properties, Lowers Price Target to $17.5 Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and lowers the price target from $18 to $17.5.